Opportunity ID: 338322
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | SP-22-003 |
| Funding Opportunity Title: | Strategic Prevention Framework for Prescription Drugs |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 93.243 — Substance Abuse and Mental Health Services Projects of Regional and National Significance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 24, 2022 |
| Last Updated Date: | Feb 24, 2022 |
| Original Closing Date for Applications: | Apr 25, 2022 |
| Current Closing Date for Applications: | Apr 25, 2022 |
| Archive Date: | May 25, 2022 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants are domestic public and private non-profit entities. |
Additional Information
| Agency Name: | Substance Abuse and Mental Health Services Adminis |
| Description: |
The purpose of the SPF Rx grant program is to provide resources to help prevent and address prescription drug misuse within a State or locality. The program is designed to raise awareness about the dangers of sharing medications as well as the risks of fake or counterfeit pills purchased over social media or other unknown sources, and work with pharmaceutical and medical communities on the risks of overprescribing. Whether addressed at the state level or by an informed community-based organization, the SPF Rx program will raise community awareness and bring prescription substance misuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, grant recipients will be required to track reductions in opioid related overdoses and incorporate relevant prescription and overdose data into strategic planning and future programming. |
| Link to Additional Information: | Strategic Prevention Framework for Prescription Drugs |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration (240) 276-1400 Email:FOACSAP@samhsa.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Packages
| Agency Contact Information: | Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (240) 276-1400 Email: FOACSAP@samhsa.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.243 | SP-22-003 | SPF Rx | PKG00272219 | Feb 24, 2022 | Apr 29, 2022 | View |
Package 1
Mandatory forms
Optional forms
Share This Post, Choose Your Platform!
About the Author: osnqt
